Bladder pain syndrome from urogynecological point of view: a narrative


  • Salah E. Shebl Department of Urology, Al Azhar University, Cairo, Egypt
  • Ayman S. Dawood Department of Obstetrics and Gynecology, Tanta University, Tanta, Egypt
  • Abdel-Ghaffar S. Dawood Department of Obstetrics and Gynecology, Tanta University, Tanta, Egypt



Bladder pain syndrome, Diagnosis, Management, Pathogenesis


Hypothesis: bladder pain syndrome (BPS) presents by both urological and gynecological symptoms. The gynecological symptoms include chronic persistent pelvic pain, dyspareunia and decreased libido on the other hand urological symptoms include wide variety of symptoms as bladder discomfort, dysuria, frequency, and urgency. Although, the definition and diagnostic criteria for the condition was established, the pathogenesis, etiology and histologic findings of BPS are still not fully understood and diagnosis is made by exclusion. Review of published data including both gynecological and urological articles focusing on the updates in the diagnostic tests, pathology and the recent therapies. The searched words were bladder pain syndrome, interstitial cystitis and painful bladder. The free full text article found after our search were 454 articles after exclusion of deficient article not covering the whole subject, 91 articles were enough for this work to be completed. From this review, Bladder pain syndrome is still unclear disease lacking curative therapy up till now and patients are still suffering and the mixed complex symptoms put further challenge on both urologists and gynecologists to solve the problem.


‎1. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The ‎standardisation of terminology of lower urinary tract function: report from the ‎Standardisation Sub-committee of the International Continence Society. Neurourol ‎Urodyn. 2002;21:167-78.

van De Merwe JP, Nordling J, Bouchelouche P, Bouchelouche K, Cervigni ‎M, ‎Daha LK, et al. Diagnostic criteria, classification, and nomenclature for ‎painful ‎bladder syndrome/interstitial cystitis: an ESSIC proposal. Eur Urol. ‎‎2008;53:60-7. ‎‏ ‏

Hanno P, Dmochowski R. Status of international consensus on ‎interstitial ‎cystitis/bladder pain syndrome/painful bladder syndrome: 2008 ‎snapshot. Neurourol ‎Urodyn. 2009;28:274-86. ‎

Clemens JQ, Joyce GF, Wise M. Interstitial cystitis and painful bladder ‎syndrome. In: Urologic Diseases in America. Edited by M. S. Litwin and C. S. Saigal. ‎Washington, DC: US Department of Healt and Human Services, Public Health ‎Service, National Institutes of Health, National Institute of Diabetes and Digestive ‎and Kidney Disease; 2007:125-154.‎

Berry SH. Prevalence of symptoms of bladder pain syndrome/interstitial cystitis ‎among adult females in the United States. J Urol. 2011;186:540. ‎

Berry SH, Bogart LM, Pham C, Liu K, Nyberg L, Stoto M. Development, validation and testing of an epidemiological case definition of interstitial cystitis/painful bladder syndrome. J Urol. 2010;183(5):1848-52.

Yoost JL, Hertweck SP, Loveless M. Diagnosis and treatment of interstitial cystitis in adolescents. J Pediatr Adolesc Gynecol. 2012;25(3):162-71.

Konkle KS, Berry SH, Elliott MN, Hilton L, Suttorp MJ, Clauw DJ, et al. Comparison of an interstitial cystitis/bladder pain syndrome clinical cohort with symptomatic community women from the RAND Interstitial Cystitis Epidemiology study. J Urol. 2012;187(2):508-12.

Lopez-Beltran A, Montironi R, Cheng L. Pathology of the urinary bladder. Cambridge University Press; 2016:48-66.

Crumley S, Ge Y, Zhou H, Shen SS, Ro JY. Interstitial cystitis: another ‎IgG4-related inflammatory disease? Ann Diagn Pathol. 2013;17:403-7.‎

Dyer AJ, Twiss CO. Painful bladder syndrome: an update and review of ‎current management strategies. Curr Urol Rep. 2014;15(2):384.‎

Mukerji G, Yiangou Y, Grogono J, Underwood J, Agarwal SK, Khullar V. Localization of M2 and M3 muscarinic receptors in human bladder disorders and their clinical correlations. J Urol. 2006;176(1):367-73.

Nazif O, Teichman JM, Gebhart GF. Neural upregulation in interstitial cystitis. Urology. 2007;69(4 Suppl):24-33.

Twiss C, Kilpatrick L, Craske M, Buffington CA, Ornitz E, Rodríguez LV. Increased startle responses in interstitial cystitis: evidence for central hyperresponsiveness to visceral related threat. J Urol. 2009;181(5):2127-33.

Keay SK, Warren JW. Is interstitial cystitis an infectious disease? Int J Antimicro Agents. 2002;19(6):480-3.

Ford AP, Gever JR, Nunn PA, Zhong Y, Cefalu JS, Dillon MP, et al. Purinoceptors as therapeutic targets for lower urinary tract dysfunction. Br J Pharmacol. 2006;147(2):S132-43.

Peters KM, Jaeger C, Killinger KA, Rosenberg B, Boura JA. Cystectomy ‎for ulcerative interstitial cystitis: sequelae and patients' perceptions of ‎improvement. Urol. 2013;82(4):829-33.‎

Hanno PM, Erickson D, Moldwin R, Faraday MM. American Urological, Association. Diagnosis and treatment of interstitial cystitis/bladder pain syndrome: AUA guideline amendment. J Urol. 2015;193(5):1545-53.

Hosseini A, Ehrén I, Wiklund NP. Nitric oxide as an objective marker ‎for evaluation of treatment response in patients with classic interstitial ‎cystitis. J Urol. 2004;172(6 Pt 1):2261-5. ‎

Tyagi P, Killinger K, Tyagi V, Nirmal J, Chancellor M, Peters KM. Urinary chemokines as noninvasive predictors of ulcerative interstitial cystitis. J Urol. 2012;187(6):2243-8.

Blalock EM, Korrect GS, Stromberg AJ, Erickson DR. Gene expression analysis of urine sediment: evaluation for potential noninvasive markers of interstitial cystitis/bladder pain syndrome. J Urol. 2012;187(2):725-32.

Kim J, Freeman MR. Antiproliferative factor signaling and interstitial ‎cystitis/painful bladder syndrome. Int Neurourol J. 2011;‎‎15(4):184-91. ‎

Kim HJ. Update on the pathology and diagnosis of interstitial ‎cystitis/bladder ‎pain syndrome: a review. Int Neurourol J. 2016;20(1):‎‎13-7.‎

Jhang JF, Kuo HC. Pathomechanism of Interstitial Cystitis/Bladder Pain Syndrome and Mapping the Heterogeneity of Disease. Int Neurourol J. 2016;20(2):95-104. ‎

Warren JW, Jackson TL, Langenberg P, Meyers DJ, Xu J. Prevalence of interstitial cystitis in first-degree relatives of patients with interstitial cystitis. Urol. 2004;63(1):17-21.

Clemens JQ, Meenan RT, Rosetti MC, Gao SY, Calhoun EA. Prevalence and incidence of interstitial cystitis in a managed care population. J Urol. 2005;173(1):98-102.

Shie JH, Liu HT, Kuo HC. Increased cell apoptosis of urothelium mediated by inflammation in interstitial cystitis/painful bladder syndrome. Urol. 2012;79(2):484.e7-484.e13.

Gu D, Huang J, Yin Y, Shan Z, Zheng S, Wu P. Long-term ketamine abuse induces cystitis in rats by impairing the bladder epithelial barrier. Mol Biol Rep. 2014;41(11):7313-22.

Nickel JC, Tripp DA, Pontari M. Childhood sexual trauma in women with ‎interstitial cystitis/bladder pain syndrome: a case control study. Can Urol Assoc J. ‎‎2011;5(6):410-5. ‎

Lorenzo Gómez MF, Gómez Castro S. Physiopathologic relationship between ‎interstitial cystitis and rheumatic, autoimmune, and chronic inflammatory ‎diseases. Arch Esp Urol. 2004;57(1):25-34. ‎

Eric S, Rovner MD. Interstitial cystitis: etiology. MedScape Reference. Available at

Hanno PM, Burks DA, Clemens JQ. AUA guideline for the diagnosis and treatment of interstitial cystitis/bladder pain syndrome. J Urol. 2011;185(6):2162-70.

Hanno PM, Burks DA, Clemens JQ. Diagnosis and treatment of interstitial cystitis/bladder pain syndrome. American Urological Association. Available at https:// / education / guidelines/ic-bladder-pain-syndrome.cfm. Accessed on 21 September 2015.

Parker KS, Crowley JR, Stephens-Shields AJ, van Bokhoven A, Lucia MS, Lai HH, et al. Urinary Metabolomics Identifies a Molecular Correlate of Interstitial Cystitis/Bladder Pain Syndrome in a Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network Cohort. E Bio Medicine. 2016;7:167-74.

Warren JW, Meyer WA, Greenberg P. Using the International Continence Society's definition of painful bladder syndrome. Urol. 2006;67:1138.

‎Fitzgerald MP, Koch D, Senka J. Visceral and cutaneous sensory testing in patients with painful ‎bladder syndrome. Neurourol Urodyn. 2005;24:627.‎

Sirinian E, Payne CK. Correlation of symptoms between 2 instruments among interstitial cystitis patients. Urol. 2001;57:124.

Warren JW, Brown J, Tracy JK. Evidence-based criteria for pain of interstitial cystitis/painful bladder syndrome in women. Urol. 2008;71:444.

Tincello DG, Walker AC. Interstitial cystitis in the UK: results of a questionnaire survey of members of the Interstitial Cystitis Support Group. Eur J Obstet Gynecol Reprod Biol. 2005;118:91.

Diggs C, Meyer WA, Langenberg P. Assessing urgency in interstitial cystitis/ painful bladder syndrome. Urol. 2007;69:210.

Greenberg P, Tracy JK, Meyer WA. Short interval between symptom onset and medical care as an indication of rapid onset of interstitial cystitis/painful bladder syndrome. BJU Int. 2007;100:599.

Dyer AJ, Twiss CO. Painful bladder syndrome: an update and review of current management strategies. Curr Urol Rep. 2014;15(2):384.

Bogart LM, Berry SH, Clemens JQ. Symptoms of interstitial cystitis, painful bladder syndrome and similar diseases in women: a systematic review. The J Urol. 2007;177(2):450-6.

Gupta P, Gaines N, Sirls LT, Peters KM. A multidisciplinary approach to the evaluation and management of interstitial cystitis/bladder pain syndrome: an ideal model of care. Transl Androl Urol. 2015;4(6):611-9.

Hanno P, Lin A, Nordling J. Bladder pain syndrome committee of the ‎International consultation on incontinence. Neurourol Urodyn. 2010;29(1):191‎-8.‎

Tyagi P, Kashyap MP, Kawamorita N, Yoshizawa T, Chancellor M, Yoshimura N. Intravesical liposome and antisense treatment for detrusor overactivity and interstitial cystitis/painful bladder syndrome. ISRN Pharmacol. 2014;(601653):1-12.

Cho YS. Interstitial Cystitis/Bladder Pain Syndrome: A Urologic Mystery. Int Neurourol J. 2016;20(1):3-4.

Colaco M, Evans R. Current guidelines in the management of interstitial cystitis. Transl Androl Urol. 2015;4(6):677-83.

Cvach K, Rosamilia A. Review of intravesical therapies for bladder pain syndrome/ interstitial. Transl Androl Urol. 2015;4(6):629-37

Oh HM, Chung ME. Botulinum toxin for neuropathic pain: a review of the literature. Toxins (Basel). 2015;7:3127-54.

Chiu B, Tai HC, Chung SD, Lori A. Birder 3,4 Botulinum Toxin A for Bladder Pain Syndrome/Interstitial Cystitis. Toxins. 2016;8:201.

Barr S. Diagnosis and management of interstitial cystitis. Obstet Gynecol Clin North Am. 2014;41:397-407.

Harris N. Treatment of bladder urothelium injury. Urologia. 2015 Oct;82 Suppl 3:S6-9.

Colaco M, Evans R. Current guidelines in the management of interstitial cystitis. Transl Androl Urol. 2015;4(6):677-83.

Oduah E, Linhardt RJ, Sharfstein ST. Heparin: past, present, and future. Pharma. 2016;9(3):38.

Nickel JC, Moldwin R, Lee S. Intravesical alkalinized lidocaine (PSD597) offers sustained relief from symptoms of interstitial cystitis and painful bladder syndrome. BJUInt. 2009;103:910-8.

Chiang G, Patra P, Letourneau R. Pentosanpolysulfate inhibits mast cell histamine secretion and intracellular calcium ion levels: an alternative explanation of its beneficial effect in interstitial cystitis. J Urol. 2000;164:2119-25.

Daha LK, Riedl CR, Lazar D. Do cystometric findings predict the results of intravesical hyaluronic acid in women with interstitial cystitis? Eur Urol 2005;47:393-7.

Jhang JF, Kuo HC. Botulinum toxin A and lower urinary tract dysfunction: pathophysiology and mechanismsof action. Toxins. 2016;8:120.

Payne CK, Mosbaugh PG, Forrest JB. Intravesical resiniferatoxin for the treatment of interstitial cystitis: a randomized, double-blind, placebo controlled trial. J Urol. 2005;173:1590-4.

Propert KJ, Mayer R, Nickel JC. Followup of patients with interstitial cystitis responsive to treatment with intravesical bacillus Calmette-Guerin or placebo. J Urol. 2008;179:552-5.

Chuang YC, Lee WC, Lee WC. Intravesical liposome versus oral pentosan polysulfate for interstitial cystitis/ painful bladder syndrome. J Urol. 2009;182:1393-400.

Payne RA, O'Connor RC, Kressin M. Endoscopic ablation of Hunner's lesions in interstitial cystitis patients. Can Urol Assoc J. 2009;3:473-7.

Hillelsohn JH, Rais-Bahrami S, Friedlander JI. Fulguration for Hunner ulcers: long-term clinical outcomes. J Urol. 2012;188:2238-41.

Hsieh CH, Chang WC, Huang MC, Su TH, Li YT, Chiang HS. Treatment of interstitial cystitis in women. Taiwan J Obstet Gynecol. 2012;51(4):526-32.

Forrest JB. Economics of interstitial cystitis in clinical practice. Rev Urol. 2002;4 Suppl 1:S44-8.

Büssing A, Ostermann T, Lüdtke R. Effects of yoga interventions on pain and pain-associated disability: a meta-analysis. J Pain. 2012;13:1-9.

Hanno PM, Burks DA, Clemens JQ. AUA guideline for the diagnosis and treatment of interstitial cystitis/ bladder pain syndrome. J Urol. 2011;185:2162-70.

Gamé X, Rischmann P, Arnal JF. Nitric oxide pathway and female lower urinary tract. Physiological and pathophysiological role. Prog Urol. 2013;23:926-35.

Pang R, Ali A. The Chinese approach to complementary and alternative medicine treatment for interstitial cystitis/bladder pain syndrome Transl Androl Urol. 2015;4(6):653-61.

Tempest H, Reynard J, Bryant RJ. Acupuncture in urological practice-a survey of urologists in England. Complement Ther Med. 2011;19:27-31.






Review Articles